Contact
How to shop
Delivery
Shopping guide
Razoxane and Dexrazoxane - Two Multifunctional Agents
Experimental and Clinical Results
English
394 b
Delivery to Austria
Up to 30 days for returns
Customers also purchased
/
Paperback
33.29
€
/
Paperback
45.79
€
Razoxane and dexrazoxane are two novel drugs with some uniquely useful features. They block cell division at the G2/M border, but nowhere else, so that they have a low toxicity profile. They suppress tumor metastasis and haemorrhages through normalization of patho-logical blood vessels. Razoxane potentiates radiotherapy especially in the treatment of soft tissue sarcomas and gastrointestinal neoplasms. §They protect normal tissues against toxic chemicals, e.g. the myocardium against anthra-cyclines or subcutaneous tissue against injuries caused by incidental extravasations of anthra-cyclines. Dexrazoxane is the only drug approved by the FDA/UMEA for the specific purpose of preventing cardiac damage when giving the widely used and effective antitumor anthra-cyclines. The reduction of cardiotoxicity is achieved without response reduction or reducing of time to progression of tumors. While the full analysis of their actions at the molecular level is not yet completely understood, it seems most likely that it is via an inhibition on the topo-isomerase II a. Moreover, the drugs have the ability to chelate several metals including iron, copper or zinc.§The protection of normal tissues is nowhere more important than that of brain, and there are indications that the proteins thought to be responsible for the ravages of Alzheimer s disease could be stabilized by one or both these drugs.
About the book
English
Categories
Give this book today
It's easy
1 Add to cart and choose Deliver as present at the checkout 2 We'll send you a voucher 3 The book will arrive at the recipient's addressYou might also be interested in
/
Paperback
47.19
€
/
Paperback
9.69
€
Hi! I'm Libroamiko, your book advisor.
How can I help you?